Heading into 2025, the chief item on argenx’s agenda is the FDA’s April 10 target action date to decide on the approval of a prefilled syringe version of Vyvgart—also known as efgartigimod ...

MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe ... Practices related to predrawing the vaccine into unmarked plastic syringes were observed that could impact patient safety ...

Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance ... the convenience of mResvia’s prefilled syringe formulation and no reported cases ...